Daily Derm Times: March 20, 2025

To stay up-to-date with the latest dermatology news, sign up to receive our eNewsletters.

The Power of Mohs Surgery for Dermatofibrosarcoma Protuberans

A 30-year-old patient with dermatofibrosarcoma protuberans faced a recurrence after initial surgery. Mohs micrographic surgery was used for precise excision, reducing recurrence risk and improving outcomes.

Multidisciplinary Approaches to Managing Challenging Basal and Squamous Cell Carcinomas

John Strasswimmer, MD, PhD, spoke on the difficulty of managing adverse effects, the role of interdisciplinary clinical relationships, and the challenges in complex and older patients.

Phase 1 Trial of PKM2 Modulator SYX-5219 for Atopic Dermatitis Underway

The phase 1a study is a first in-human trial evaluating SYX-5219 for AD.

Dupilumab and AD: Pediatric Ocular Adverse Effects

A recent study highlights the need for ophthalmologic monitoring in pediatric dupilumab therapy.

Long-Term Safety and Efficacy of Ixekizumab in Japanese Patients with Psoriasis

This real-world data explores the use of the IL-17A blocker for up to 3 years in several subtypes of psoriasis.

New Research Confirms Effective Therapy for Nail Psoriasis

Nail psoriasis affects 50% of plaque psoriasis patients, making effective treatments crucial.

Review Findings Suggest Melanoma and Hidradenitis Suppurativa Are Risk Factors for Completed Suicide

The review also found that female patients with non melanoma skin cancer demonstrated a greater risk of completed suicide compared to members of a control group.